Synergistic effect on the treatment of menorrhagia by endometrial biopsy followed by contemporaneous insertion of the levonorgestrel intrauterine system
article
OA: closed
CC0
AI-generated summary
Endometrial biopsy followed by levonorgestrel-releasing intrauterine system insertion effectively treated menorrhagia in 93.5% of women with benign causes over one year.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: To evaluate the efficacy of endometrial biopsy followed by intrauterine system-releasing levonorgestrel (LNG-IUS) insertion in the treatment of women with menorrhagia. METHOD: This was a retrospective, non-comparative study. Ninety-two patients who had menorrhagia due to non-malignant causes were sequentially recruited into the study over a 3-year period (age range 29-51 years). Patients with a uterine size more than 12 weeks were not included. A LNG-releasing intrauterine system was inserted during the mid-cycle immediately after an endometrial biopsy was taken. One year after the closure of the study period, the women recruited were then contacted by telephone or by direct questioning at the outpatient clinic as to the outcome of the above treatment. RESULTS: The most common (15%) complaint regarding bleeding patterns at 3-6 months after insertion was spotting and intermenstrual bleeding. Following the introduction of the LNG-IUS, six women required a hysterectomy for various reasons. The remaining 86 women (93.5%) continued the use of LNG-IUS. CONCLUSION: LNG-IUS following an endometrial biopsy is an effective treatment for menorrhagia due to benign causes and could be an alternative to other forms of medical and surgical treatments.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
References (13)
- Medical and surgical management of adenomyosis via openalex
- The evaluation of the effectiveness of an intrauterine-administered progestogen (levonorgestrel) in the symptomatic treatment of endometriosis and in the staging of the disease via openalex
- Therapeutic Use of the LNG IUS, and Counseling via openalex
- doi:10.1016/j.contraception.2006.12.016 via openalex
- doi:10.3109/00016340903322776 via openalex
- doi:10.1783/147118900101194571 via openalex
- doi:10.1016/s0039-128x(00)00177-x via openalex
- W112703062 via openalex
- doi:10.1093/humrep/dei476 via openalex
- doi:10.1016/j.ijgo.2011.07.031 via openalex
- doi:10.1783/147118902101196225 via openalex
- doi:10.1016/j.contraception.2007.01.015 via openalex
- doi:10.1016/j.bpobgyn.2006.03.003 via openalex
Source provenance
- openalex
- last seen: 2026-05-11T06:02:20.344922+00:00
- unpaywall
- last seen: 2026-06-13T06:42:57.164913+00:00
License: CC0
· commercial use OK